Medifast
MED
$33.71
Share price
0.63%
Change (1 day)
-63.03%
Change (1 year)
Categories
Operating Margin for Medifast (MED)
Operating Margin as of April 2024 (TTM): 14.16%
According to Medifast's latest financial reports and stock price the company's current Operating Margin is 14.16%. At the end of 2021 the company had an Operating Margin of 14.16%.
Operating Margin history for Medifast from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 14.16% | -1.39% |
| 2020 | 14.36% | 10.98% |
| 2019 | 12.94% | -8.09% |
| 2018 | 14.08% | 5.3% |
| 2017 | 13.37% | 35.36% |
| 2016 | 9.88% | -9.18% |
| 2015 | 10.88% | -2.09% |
| 2014 | 11.11% | 15.97% |
| 2013 | 9.58% | 39.71% |
| 2012 | 6.86% | -26.14% |
| 2011 | 9.28% | -24.56% |
| 2010 | 12.31% | 5.63% |
| 2009 | 11.65% | 56.48% |
| 2008 | 7.44% | 12.52% |
| 2007 | 6.62% | -33.2% |
| 2006 | 9.90% | 1.14% |
| 2005 | 9.79% | -7.86% |
| 2004 | 10.63% | -24.18% |
| 2003 | 14.02% | 1.93% |
| 2002 | 13.75% | 22.04% |
| 2001 | 11.27% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -356.78% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | -1,742.07% | -12,402.75% | 🇺🇸 USA |
 Bellerophon Therapeutics
BLPH | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.